At Cochlear, our engineers push the boundaries of technology to make sure each generation of
We understand that innovation requires significant investment. This is why we invest more than AU$160 million a year in research and development. The result is more than 100 registered patent families and multiple industry awards.
We also believe that collaboration in cutting-edge research is pivotal to innovation. Besides employing some of the world's best engineers in our global team of more than 350 research and development staff, we collaborate with over 100 research centres in more than 20 countries.
What opportunities does Cochlear have for engineers?
There are Cochlear engineering careers to suit people with different levels of expertise – some are highly technical, others more managerial or support functions. We offer permanent and contract opportunities in a broad range of roles including:
- Departmental managers and team leaders
- DSP, firmware and ASIC engineers
- Device analysis engineer
- Electrical/electronic engineers
- Manufacturing engineers
- Material science engineers
- Mechanical engineers
- Mechatronic engineers
- New product industrialisation engineers
- Process engineers
- Production engineers
- Project engineers
- Program managers
- Quality engineers
- Research engineers
- Reliability engineers
- RF engineers
- Risk management engineers
- Software engineers
- Sustaining/product lifecycle engineering
- Systems engineers
- Systems usability engineers
- Test systems engineers
- Verification and validation engineers
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.